Ralph Rothenberg
Rheumatology · Youngstown, OHNPI 1548266190
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 367 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,501 and has fallen 82.9% since, to $427 in 2023.
Across 367 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$915
- Johnson & Johnson$630
- Novartis$507
- AbbVie$485
- UCB, Inc.$415
- Pfizer$303
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,29997%
- Education$1793%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 53 | $915 |
| Johnson & Johnson | 46 | $630 |
| Novartis | 33 | $507 |
| AbbVie | 36 | $485 |
| UCB, Inc. | 25 | $415 |
| Pfizer | 21 | $303 |
| Lilly USA, LLC | 18 | $295 |
| GSK | 15 | $260 |
| Genentech USA, Inc. | 32 | $259 |
| Mallinckrodt Hospital Products Inc. | 11 | $240 |
| Mallinckrodt Enterprises LLC | 11 | $197 |
| Actelion Pharmaceuticals US, Inc. | 7 | $159 |
| E.r. Squibb & Sons, L.L.C. | 22 | $150 |
| Aurinia Pharma U.S., Inc. | 6 | $133 |
| Regeneron Healthcare Solutions, Inc. | 6 | $110 |
| AstraZeneca | 6 | $99 |
| Hikma Pharmaceuticals USA | 4 | $78 |
| Boehringer Ingelheim | 3 | $48 |
| Bristol Myers Squibb | 2 | $34 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $34 |
| Ultragenyx Pharmaceutical Inc. | 2 | $29 |
| Sobi, Inc | 2 | $27 |
| Sebela Pharmaceuticals Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Medexus Pharma, Inc. | 1 | $13 |
How this compares
$5,478 in reported general payments places this provider in the 70th percentile of 255 rheumatology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 13 | $255 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Youngstown
- Leonard CalabreseCleveland$1.9M
- Gregory DelorenzoCincinnati$1.3M
- Alexa MearaColumbus$426K
- Chad DealCleveland$375K
- David MandelMayfield Village$352K
- Muhammad KhanCleveland$262K
- Chacko AlappattMiamisburg$258K
- Adam BrownCleveland$247K
- Nikita HegdeStow$198K
- M Elaine HusniCleveland$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.